Showing results (311-320 of 411) with videos related to

Sort By:
Pageof 42
Journal of Neurochemistry|January 27, 2007
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 loadJens Wiltfang, Hermann Esselmann, Mirko Bibl, et al.
Psychiatry Research|May 25, 2010
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's diseaseStefan J Teipel, Michael Ewers, Stefanie Wolf, et al.
Journal of Neurochemistry|August 11, 2022
Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuumAlessandro Galgani, Andrea Vergallo, Nicole Campese, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Nature Aging|April 28, 2023
Designing the next-generation clinical care pathway for Alzheimer's diseaseHarald Hampel, Rhoda Au, Soeren Mattke, et al.
Dialogues in Clinical Neuroscience|October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
Harald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease ConsortiumGiovanni B Frisoni, Wouter J P Henneman, Michael W Weiner, et al.
Biochemical Pharmacology|November 27, 2013
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020Harald Hampel, Simone Lista, Stefan J Teipel, et al.
Neurobiology of Aging|October 5, 2019
Biomarker-guided clustering of Alzheimer's disease clinical syndromesNicola Toschi, Simone Lista, Filippo Baldacci, et al.
Pageof 42